Manulife/John Hancock Enters 5-Year, Research Collaboration With MIT AgeLab, Driving Longevity Innovation And Research
Manulife/John Hancock Enters 5-Year, Research Collaboration With MIT AgeLab, Driving Longevity Innovation And Research
Announces longevity preparedness research; builds on insurer's commitment to help people live longer, healthier, better lives
宣佈長壽準備研究；建立在保險公司幫助人們更長壽、更健康、更美好生活的承諾基礎上
BOSTON, May 14, 2024 /PRNewswire/ - John Hancock, along with its Toronto-based parent company Manulife (NYSE:MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of life for the aging population and their loved ones. Over the next five years, Manulife/John Hancock and the MIT AgeLab will collaborate to research the future of longevity innovation, developing research, thought leadership, and workshops with the goal of driving actionable insights for the business community, policymakers, and individuals and their families.
波士頓，2024年5月14日 /PRNewswire/ ——約翰·漢考克及其總部位於多倫多的母公司宏利（紐約證券交易所代碼：MFC）今天宣佈與麻省理工學院（MIT）AgeLab進行爲期五年、耗資數百萬美元的研究合作。AgeLab是一家多學科研究機構，與企業、政府和非政府組織合作，領導創新和研究，幫助改善老齡化人口及其親人的生活質量。在未來五年中，宏利/約翰·漢考克和麻省理工學院AgeLab將合作研究長壽創新的未來，開展研究、思想領導力和研討會，目標是爲商界、決策者、個人及其家庭提供切實可行的見解。
譯文內容由第三人軟體翻譯。